Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 30;13(9):2640.
doi: 10.3390/jcm13092640.

Characterization of Perioperative Serotonin in Patients Undergoing Orthotopic Liver Transplantation

Affiliations

Characterization of Perioperative Serotonin in Patients Undergoing Orthotopic Liver Transplantation

Tobias Zott et al. J Clin Med. .

Abstract

Background: Platelets were shown to be relevant for liver regeneration. In particular, platelet-stored serotonin (5-HT) proved to be a pro-regenerative factor in this process. The present study aimed to investigate the perioperative course of 5-HT and evaluate associations with patient and graft outcomes after othotopic liver transplantation (OLT). Methods: 5-HT was quantified in plasma and serum of 44 OLT recipients perioperatively, and in their respective donors. Olthoff's criteria for early allograft dysfunction (EAD) were used to evaluate postoperative outcomes. Results: Patients with higher donor intra-platelet 5-HT per platelet (IP 5-HT PP) values had significantly lower postoperative transaminases (ASAT POD1: p = 0.006, ASAT POD5: p = 0.006, ASAT POD10: p = 0.02, ALAT POD1: p = 0.034, ALAT POD5: p = 0.017, ALAT POD10: p = 0.04). No significant differences were seen between postoperative 5-HT values and the occurrence of EAD. A tendency was measured that donor IP 5-HT PP is lower in donor-recipient pairs that developed EAD (p = 0.07). Conclusions: Donor IP 5-HT PP might be linked to the postoperative development of EAD after OLT, as higher donor levels are correlated with a more favorable postoperative course of transaminases. Further studies with larger cohorts are needed to validate these findings.

Keywords: liver regeneration; liver transplantation; serotonin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Timeline of blood sample acquisition. Two preoperative (donor and recipient) and three postoperative blood withdrawals on day one (POD 1), five (POD 5) and ten (POD 10).
Figure 2
Figure 2
Perioperative course of serum- (A), plasma- (B) and IP 5-HT (C) as well as IP 5-HT PP (D). Significant differences are highlighted. * p < 0.05. ** p < 0.005.
Figure 3
Figure 3
No significant differences in the recipients’ perioperative course of serum- (A), plasma- (B) and IP 5-HT (C) as well as IP 5-HT PP (D), each dichotomized by EAD.
Figure 4
Figure 4
Donor values of serum- (A), plasma- (B) and IP 5-HT (C) as well as IP 5-HT PP (D), each dichotomized by EAD. Moreover, the tendency of lower donor IP 5-HT PP in patients that later develop EAD can be seen in Subfigure D.
Figure 5
Figure 5
Comparison of liver parameters with our cohort dichotomized by median donor IP 5-HT PP. Platelet count (A), prothrombin ratio (B), bilirubin (C), GGT (D), ALAT (E) and ASAT (F) are shown. The significant differences in ASAT and ALAT are highlighted. * p < 0.05.
Figure 6
Figure 6
Scatter plots of donor IP 5-HT PP and donor values of GGT (A) and LDH (B) with.

References

    1. Müller P.C., Kabacam G., Vibert E., Germani G., Petrowsky H. Current status of liver transplantation in Europe. Int. J. Surg. 2020;82:22–29. doi: 10.1016/j.ijsu.2020.05.062. - DOI - PubMed
    1. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R.B., Port F.K., Wolfe R.A. The survival benefit of liver transplantation. Am. J. Transplant. 2005;5:307–313. doi: 10.1111/j.1600-6143.2004.00703.x. - DOI - PubMed
    1. Patel P., DiNorcia J. The devil is in the detail: Current management of perioperative surgical complications after liver transplantation. Curr. Opin. Organ. Transplant. 2019;24:138–147. doi: 10.1097/MOT.0000000000000616. - DOI - PubMed
    1. Watt K.D., Pedersen R.A., Kremers W.K., Heimbach J.K., Charlton M.R. Evolution of Causes and Risk Factors for Mortality Post Liver Transplant: Results of the NIDDK Long Term Follow-up Study. Am. J. Transplant. 2010;10:1420–1427. doi: 10.1111/j.1600-6143.2010.03126.x. - DOI - PMC - PubMed
    1. Masior Ł., Grąt M. Primary Nonfunction and Early Allograft Dysfunction after Liver Transplantation. Dig. Dis. 2022;40:766–776. doi: 10.1159/000522052. - DOI - PubMed

LinkOut - more resources